Huadong Medicine News and Activities

Huadong Medicine is one of the...

• CSI 300;
• Fortune 500 China (#373);
• TOB Iconic 10,000.

Huadong Medicine is a company listed under the stock ticker 000963 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Huadong Medicine

• Liang Lu, Chief Executive Officer
• Ruwei Wang, Independent Director
• Feipeng Zhu, Director

Create your alert
to follow the executive moves at Huadong Medicine.

Huadong Medicine has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Huadong Medicine

Social media about Huadong Medicine

• Huadong Medicine on Wikipedia, Google News & Yahoo Finance
• Huadong Medicine on LinkedIn, X (Twitter) & YouTube